Literature DB >> 26009787

Mechanisms of symptom reduction in a combined treatment for comorbid posttraumatic stress disorder and alcohol dependence.

Carmen P McLean1, Yi-Jen Su2, Edna B Foa3.   

Abstract

OBJECTIVE: To examine the mechanisms of prolonged exposure (PE) and naltrexone (NAL) that underlie symptom reduction among individuals with comorbid posttraumatic stress disorder (PTSD) and alcohol dependence (AD). We hypothesized that (a) reduction in negative cognitions mediates PTSD improvement during PE; (b) reduction in alcohol craving mediates reduction in drinking frequency during NAL treatment; and (c) PTSD improvement mediates reduction in craving and alcohol use during PE.
METHOD: Participants were 159 individuals meeting the DSM-IV diagnosis of PTSD and AD randomly assigned to 1 of 4 conditions: PE + NAL, PE + placebo (PBO), supportive counseling (SC) + NAL; and SC + PBO. All participants received supportive counseling.
RESULTS: Lagged multilevel mediational analyses indicated that (a) a reciprocal relationship between cognitive change and PTSD improvement was observed in PE + NAL, PE + PBO, and SC + NAL, but not in SC + PBO; (b) reduction in craving significantly mediated subsequent decrease in alcohol use in PE + NAL and SC + PBO, but not in PE + PBO and SC + NAL; and (c) PTSD improvement significantly mediated subsequent reduction of craving in PE + PBO, and mediated decrease in alcohol use in PE + NAL.
CONCLUSIONS: The efficacy of combining PE and NAL for reducing alcohol use among those with comorbid PTSD/AD seems to be through reduction in both PTSD symptoms and craving. These findings shed light on the mechanism of PE and highlight the central role of PTSD in the maintenance of alcohol craving and use in patients with comorbid PTSD/AD. (c) 2015 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26009787      PMCID: PMC4445454          DOI: 10.1037/ccp0000024

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  15 in total

1.  The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties.

Authors:  W Fals-Stewart; T J O'Farrell; T T Freitas; S K McFarlin; P Rutigliano
Journal:  J Consult Clin Psychol       Date:  2000-02

2.  A meta-analytic review of prolonged exposure for posttraumatic stress disorder.

Authors:  Mark B Powers; Jacqueline M Halpern; Michael P Ferenschak; Seth J Gillihan; Edna B Foa
Journal:  Clin Psychol Rev       Date:  2010-05-02

3.  Psychometric properties of the Penn Alcohol Craving Scale.

Authors:  B A Flannery; J R Volpicelli; H M Pettinati
Journal:  Alcohol Clin Exp Res       Date:  1999-08       Impact factor: 3.455

4.  Methods for inducing alcohol craving in individuals with co-morbid alcohol dependence and posttraumatic stress disorder: behavioral and physiological outcomes.

Authors:  Laura E Kwako; Melanie L Schwandt; Joanna R Sells; Vijay A Ramchandani; Daniel W Hommer; David T George; Rajita Sinha; Markus Heilig
Journal:  Addict Biol       Date:  2014-05-07       Impact factor: 4.280

5.  A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.

Authors:  J Balldin; M Berglund; S Borg; Marianne Månsson; P Bendtsen; J Franck; L Gustafsson; J Halldin; L H Nilsson; G Stolt; A Willander
Journal:  Alcohol Clin Exp Res       Date:  2003-07       Impact factor: 3.455

6.  Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers.

Authors:  Dena Davidson; Chandan Saha; Stephanie Scifres; Joanne Fyffe; Sean O'Connor; Christopher Selzer
Journal:  Addict Behav       Date:  2004-08       Impact factor: 3.913

7.  Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?

Authors:  Kylie Richardson; Andrew Baillie; Sophie Reid; Kirsten Morley; Maree Teesson; Claudia Sannibale; Martin Weltman; Paul Haber
Journal:  Addiction       Date:  2008-06       Impact factor: 6.526

8.  Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.

Authors:  Edna B Foa; David A Yusko; Carmen P McLean; Michael K Suvak; Donald A Bux; David Oslin; Charles P O'Brien; Patricia Imms; David S Riggs; Joseph Volpicelli
Journal:  JAMA       Date:  2013-08-07       Impact factor: 56.272

9.  Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy.

Authors:  Jay C Fournier; Robert J DeRubeis; Steven D Hollon; Robert Gallop; Richard C Shelton; Jay D Amsterdam
Journal:  Behav Res Ther       Date:  2013-04-12

10.  Change in negative cognitions associated with PTSD predicts symptom reduction in prolonged exposure.

Authors:  Alyson K Zalta; Seth J Gillihan; Aaron J Fisher; Jim Mintz; Carmen P McLean; Rachel Yehuda; Edna B Foa
Journal:  J Consult Clin Psychol       Date:  2013-11-04
View more
  11 in total

Review 1.  Treating Posttraumatic Stress Symptoms Among People Living with HIV: a Critical Review of Intervention Trials.

Authors:  Carmen P McLean; Hayley Fitzgerald
Journal:  Curr Psychiatry Rep       Date:  2016-09       Impact factor: 5.285

Review 2.  An empirical review of potential mediators and mechanisms of prolonged exposure therapy.

Authors:  Andrew A Cooper; Erin G Clifton; Norah C Feeny
Journal:  Clin Psychol Rev       Date:  2017-07-11

3.  Changes in negative cognitions mediate PTSD symptom reductions during client-centered therapy and prolonged exposure for adolescents.

Authors:  Carmen P McLean; Rebecca Yeh; David Rosenfield; Edna B Foa
Journal:  Behav Res Ther       Date:  2015-03-20

4.  Trauma cognitions are related to symptoms up to 10 years after cognitive behavioral treatment for posttraumatic stress disorder.

Authors:  Christine D Scher; Michael K Suvak; Patricia A Resick
Journal:  Psychol Trauma       Date:  2017-02-09

5.  Do changes in trauma-related beliefs predict PTSD symptom improvement in prolonged exposure and sertraline?

Authors:  Andrew A Cooper; Lori A Zoellner; Peter Roy-Byrne; Matig R Mavissakalian; Norah C Feeny
Journal:  J Consult Clin Psychol       Date:  2017-05-15

Review 6.  Psychological Mechanisms of PTSD and Its Treatment.

Authors:  Rebecca K Sripada; Sheila A M Rauch; Israel Liberzon
Journal:  Curr Psychiatry Rep       Date:  2016-11       Impact factor: 5.285

7.  Confounding in statistical mediation analysis: What it is and how to address it.

Authors:  Matthew J Valente; William E Pelham; Heather Smyth; David P MacKinnon
Journal:  J Couns Psychol       Date:  2017-11

8.  Cognitive Mediation of Symptom Change in Exposure and Response Prevention for Obsessive-Compulsive Disorder.

Authors:  Yi-Jen Su; Joseph K Carpenter; Laurie J Zandberg; Helen Blair Simpson; Edna B Foa
Journal:  Behav Ther       Date:  2016-03-31

9.  Islamic Trauma Healing: Integrating Faith and Empirically Supported Principles in a Community-Based Program.

Authors:  Jacob A Bentley; Norah C Feeny; Michael L Dolezal; Alexandra Klein; Libby H Marks; Belinda Graham; Lori A Zoellner
Journal:  Cogn Behav Pract       Date:  2020-11-20

Review 10.  Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.

Authors:  Neil P Roberts; Pamela A Roberts; Neil Jones; Jonathan I Bisson
Journal:  Cochrane Database Syst Rev       Date:  2016-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.